Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0340 Transporter Info
Gene Name	SLC39A12
Transporter Name	Zinc transporter ZIP12
Gene ID	221074
UniProt ID	Q504Y0

Post-Translational Modification of This DT
Overview of SLC39A12 Modification Sites with Functional and Structural Information
Sequence	M C F R T K L S V S W V P L F L L L S R V F S T E T D K P S A Q D S R S R G S S G Q P A D L L Q V L S A G D H P P H N H S R S L I K T L L E K T G C P R R R N G M Q G D C N L C F E P D A L L L I A G G N F E D Q L R E E V V Q R V S L L L L Y Y I I H Q E E I C S S K L N M S N K E Y K F Y L H S L L S L R Q D E D S S F L S Q N E T E D I L A F T R Q Y F D T S Q S Q C M E T K T L Q K K S G I V S S E G A N E S T L P Q L A A M I I T L S L Q G V C L G Q G N L P S P D Y F T E Y I F S S L N R T N T L R L S E L D Q L L N T L W T R S T C I K N E K I H Q F Q R K Q N N I I T H D Q D Y S N F S S S M E K E S E D G P V S W D Q T C F S A R Q L V E I F L Q K G L S L I S K E D F K Q M S P G I I Q Q L L S C S C H L P K D Q Q A K L P P T T L E K Y G Y S T V A V T L L T L G S M L G T A L V L F H S C E E N Y R L I L Q L F V G L A V G T L S G D A L L H L I P Q V L G L H K Q E A P E F G H F H E S K G H I W K L M G L I G G I H G F F L I E K C F I L L V S P N D K Q G L S L V N G H V G H S H H L A L N S E L S D Q A G R G K S A S T I Q L K S P E D S Q A A E M P I G S M T A S N R K C K A I S L L A I M I L V G D S L H N F A D G L A I G A A F S S S S E S G V T T T I A I L C H E I P H E M G D F A V L L S S G L S M K T A I L M N F I S S L T A F M G L Y I G L S V S A D P C V Q D W I F T V T A G M F L Y L S L V E M L P E M T H V Q T Q R P W M M F L L Q N F G L I L G W L S L L L L A I Y E Q N I K I
PTM type	X-Oxidation X-Phosphorylation X: Amino Acid

Oxidation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC39A12			[1]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	464
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC39A12 Cystine 464 has the potential to affect its expression or activity.
Phosphorylation
Serine	14 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC39A12			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	63
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A12 Serine 63 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC39A12			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	178
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A12 Serine 178 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC39A12			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	180
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A12 Serine 180 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC39A12			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	289
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A12 Serine 289 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC39A12			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	292
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A12 Serine 292 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC39A12			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	293
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A12 Serine 293 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC39A12			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	294
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A12 Serine 294 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC39A12			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	326
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A12 Serine 326 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC39A12			[3] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	337
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A12 Serine 337 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC39A12			[3] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	346
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A12 Serine 346 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SLC39A12			[3] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	348
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A12 Serine 348 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SLC39A12			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	517
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A12 Serine 517 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence SLC39A12			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	526
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A12 Serine 526 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence SLC39A12			[7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	530
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A12 Serine 530 has the potential to affect its expression or activity.
Threonine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC39A12			[3]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	177
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A12 Threonine 177 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC39A12			[3]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	185
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A12 Threonine 185 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC39A12			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	528
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A12 Threonine 528 has the potential to affect its expression or activity.
Tyrosine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC39A12			[3]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	174
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A12 Tyrosine 174 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC39A12			[4]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	288
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A12 Tyrosine 288 has the potential to affect its expression or activity.

References
1	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
2	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
3	Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics. Mol Cell Proteomics. 2013 Dec;12(12):3851-73.
4	Sequential enrichment with titania-coated magnetic mesoporous hollow silica microspheres and zirconium arsenate-modified magnetic nanoparticles for the study of phosphoproteome of HL60 cells. J Chromatogr A. 2014 Oct 24;1365:54-60.
5	Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
6	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
7	Phosphoproteomic Analysis of Aurora Kinase Inhibition in Monopolar Cytokinesis. J Proteome Res. 2015 Sep 4;14(9):4087-98.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence